Trivium Point Advisory, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1766564
WILTON, CT
Position in VRTX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,092,309
-$283,480 QoQ
Shares Held
2,199
-28.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#820
of 1,735 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Trivium Point Advisory, LLC holds $1,092,309 across 1 Biotechnology name. VRTX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,199 | $1,092,309 |
All Filings in VRTX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,092,309 | 2,199 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,375,789 | 3,081 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,947,181 | 4,295 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,301,668 | 5,877 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,366,602 | 7,562 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $3,861,106 | 7,964 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,329,926 | 8,269 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,587,627 | 7,714 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,806,475 | 8,121 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,859,606 | 6,841 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,992,133 | 4,896 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $520,566 | 1,497 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $508,861 | 1,446 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $446,139 | 1,416 | Shares | Sole | 2023-04-12 | |
| No filing history on record for this holder in this stock. | ||||||